chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Snake-like skin; Red bumps/rashes spread all over the body; Burning rashes; Itching rashes; Sandy-like skin; Leathery skin; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Mar-2021 and was forwarded to Moderna on 19-Mar-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ICHTHYOSIS (Snake-like skin), RASH ERYTHEMATOUS (Red bumps/rashes spread all over the body), SKIN BURNING SENSATION (Burning rashes) and RASH PRURITIC (Itching rashes) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced ICHTHYOSIS (Snake-like skin) (seriousness criterion medically significant), RASH ERYTHEMATOUS (Red bumps/rashes spread all over the body) (seriousness criterion disability), SKIN BURNING SENSATION (Burning rashes) (seriousness criterion disability), RASH PRURITIC (Itching rashes) (seriousness criterion disability), KERATOSIS PILARIS (Sandy-like skin) and LICHENIFICATION (Leathery skin). At the time of the report, ICHTHYOSIS (Snake-like skin), RASH ERYTHEMATOUS (Red bumps/rashes spread all over the body), SKIN BURNING SENSATION (Burning rashes), RASH PRURITIC (Itching rashes), KERATOSIS PILARIS (Sandy-like skin) and LICHENIFICATION (Leathery skin) had not resolved.            No concomitant medications reported. Treatment medications included diphenhydramine and 6-day pack prednisone.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient received varicella vaccine on 9-9-08.  Was exposed to shingles by father.  Positive chicken pox in office on 10-6-08.
Both my wife and I received the first dose of the Shringix vaccine and were adversely affected much more than we expected or heard about from other people who got the same vaccine. Our arms were sore on the day of the vaccine. On the second day we both felt like we had the flu and laid around all day on the couches/rockers sleeping and watch TV. On the third day we still felt weak, but returned to normal activities on the light side. From all indications, we expected soreness at the sight of the vaccine, but didn't expect to feel like we caught the flu.
patient reports vaccination site with red mark "rash"  for 12 days past vaccination concern for extremity achiness  day 3-12 post vaccination
I had a breakthrough Covid infection after having 4 doses of the Pfizer vaccine. Symptoms of a Covid infection started on July 30, 2022 (Day 0) while outdoors at a picnic. I thought the symptoms were due to outdoor allergies as I started feeling a scratchy throat while outside. I took an antigen test that afternoon that came back negative. I started feeling slightly chilled that same evening. On July 31 (Day 1) I took two more antigen tests one in the morning and one in the evening that both came back negative, and I was feeling a scratchy throat. On August 1 (Day 2), I tested negative on an antigen test in the morning. After an afternoon nap on August 1, I woke up with a very hoarse sore throat, the back of my neck was sore and stiff.  I also had muscle soreness.  On August 2 (Day 3), I had a virtual visit with my primary care practice.  They did prescribe me Paxlovid, but my normal primary care physician advised me not to take it due to my slightly elevated liver counts. I also went for a PCR test on August 2 which came back positive on August 3. Other symptoms started to increase as well - an extreme sore throat like fire, fatigue, headache, coughing. On August 4 (Day 4) my nose started burning as well, then on August 5 (Day 6) I lost my sense of smell which did not come back for about one week. I continued to test positive on antigen tests until August 12 (Day 13) when I finally tested negative. At that point I still had a cough, nasal congestion, and fatigue. I had an in person visit with my regular primary care doctor as a follow up the the covid infection on August 16. At that point my lungs sounded clear and my heart sounded normal. The following week on August 22, 2022 I was allowed to resume my physical therapy for hip surgery that I had on May 2, 2022 with slow graded exercise due to the Covid infection. At that point I started feeling heart palpitations, a much higher heart rate than normal, more shortness of breath and continuing fatigue. These symptoms I am still continuously feeling. So I had a cardiologist appointment virtually on August 29 to discuss these symptoms as post covid issues which he believes could be POTS and tachycardia related to Covid. He had me do an echocardiogram on September 6 to rule out any structural abnormality and pericardial effusion. The echo came back with all normal results on September 6. He will be following up in an appointment on September 19 to discuss further treatment.
Slept all day"; Fatigue; Headache; Muscle pain in injected arm; Chills; Fever of 102.1; Sore arm at injection site; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Slept all day"), INJECTION SITE PAIN (Sore arm at injection site), FATIGUE (Fatigue), HEADACHE (Headache) and MYALGIA (Muscle pain in injected arm) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Jan-2021, the patient experienced INJECTION SITE PAIN (Sore arm at injection site). On 05-Feb-2021, the patient experienced FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle pain in injected arm), CHILLS (Chills) and PYREXIA (Fever of 102.1). On 06-Feb-2021, the patient experienced SOMNOLENCE (Slept all day"). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. At the time of the report, SOMNOLENCE (Slept all day"), INJECTION SITE PAIN (Sore arm at injection site), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle pain in injected arm), CHILLS (Chills) and PYREXIA (Fever of 102.1) outcome was unknown.
Pt reported small fluid filled blisters on left arm after first zoster vaccine(shingrex) and 2nd dose was held.
Metallic taste to food; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administered in arm left, administration date 14Apr2021 14:00 (Lot number: EW0158) at the age of 68 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "allergies" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "High cholesterol" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1; Lot Number: ER2613; at 14:00; administered in left arm.), administration date: 24Mar2021, when the patient was 68 years old, for Covid-19 immunization, reaction(s): "Metallic taste", "Body aches", "Extremely tired".  The following information was reported: DYSGEUSIA (non-serious) with onset 14Apr2021, outcome "recovered" (15Apr2021), described as "Metallic taste to food". Therapeutic measures were not taken as a result of dysgeusia.  Additional information: The patient did not receive other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient did not have COVID-19. Since the vaccination, the patient had not been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.
Swelling, redness, fever saw MD who prescribed ice, elevation, ibuprofen and clindamycin (however pt did not fill clindamycin).
experienced severe body pains; specifically back of the neck and lower back; Initial information received on 15-Nov-2023 regarding an unsolicited valid  non-serious case received from a consumer/non-health care professional.  This case involves a 57 years old female patient who experienced severe body pains and specifically back of the neck and lower back while receiving vaccine Influenza Quadrival A-B Vaccine [Fluzone Quadrivalent].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   In 2022, the patient received an unknown dose of suspect Influenza Quadrival A-B Vaccine (unknown formulation, strength, batch number and expiry date) via unknown route in unknown administration site for prophylactic vaccination(Immunization). Information regarding batch number has been requested.  In 2022 the patient developed a non-serious experienced severe body pains (pain) AND of the neck and lower back (neck pain) (unknown latency) following the administration of Influenza Quadrival A-B Vaccine.  It was reported that Patient reported that last year when she received the Sanofi Flu product she had a bad reaction, and she did not report it at the time. She received the shot late afternoon on a Thursday and by Friday she was "flat out on the bed. She is not sure if the product she received last year was the Flublok or the Fluzone QIV  Action taken;  not applicable.  It was not reported if the patient received a corrective treatment for both the events. (experienced severe body pains, specifically back of the neck and lower back).  At time of reporting, the outcome was Recovered / Resolved on an unknown date for both the events.
Swollen lymph node under right under arm,  swelling, redness at injection site, fever
Swollen under arm pit in left arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 10Sep2021 (Batch/Lot number: unknown) at the age of 52 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "High Blood pressure" (unspecified if ongoing). Concomitant medication(s) included: LOTREL [AMLODIPINE BESILATE;BENAZEPRIL HYDROCHLORIDE]; GINKO BILOBA [GINKGO BILOBA]. Past drug history included: Demerol, reaction(s): "known allergies", notes: known allergies: Demerol.  The following information was reported: SWELLING (non-serious) with onset 10Oct2021 08:00, outcome "not recovered", described as "Swollen under arm pit in left arm". Therapeutic measures were not taken as a result of swelling.  Additional information: The patient did not take any other vaccine in four weeks. The patient took Lotrel, apple cider vinegar gummies, ginko biloba in two weeks. The patient did not have Covid prior vaccination and not Covid tested post vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt said has a red rash and pain at injection site. Told patient to apply cold packs and take Tylenol. Pt said rash has gone down from half dollar size to quarter size but still painful.
redness; warm/hot feel on her face; itching; Swelling of the Face; face is red and blotchy, she is not sure if it is a rash, but the texture is not as smooth as usual, she would say it is rough; face is red and blotchy, she is not sure if it is a rash, but the texture is not as smooth as usual, she would say it is rough; Face is Flushed; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6199; Expiration Date: Jun2021) via an unspecified route of administration, administered in left arm on 13Mar2021 at 13:00 as dose 1, single (at the age of 65-year-old) for covid-19 immunisation. The patient medical history was not reported. The patient previously took Bactrim for UTI from 22Feb2021 to 03Mar2021, stated that she stopped the medication ten days before the vaccine, there were 20 pills, and she took it twice a day for 10 days, and she took all of them as 800/160mg tablet twice a day by mouth. Concomitant medications included ongoing Fiber as 500 mg, 1x/day via orally and Doxylamine succinate taken for sleep aid from an unspecified start date and ongoing as 50 mg, 1x/day (at bedtime) via orally. No additional vaccines was administered prior 4 weeks or on same date of the Pfizer suspect. Prior Vaccinations (within 4 weeks) reported as none, states she has not had a vaccine in a million years, well 20 years. Patient stated when she woke up Wednesday morning (17Mar2021 at 08:00) she had facial swelling and was flushed and so fourth, and it didn't go down during the day, it was not markedly worse but a little worse, certainly no better. Clarifies that her tongue and throat were normal. She states that she was not on any daily prescription medications, just two over the counter ones. On an unspecified date, she experience some swelling in the face, redness and warm/hot feel on her face, also some itching. Since, she was taking her second dose tomorrow, she just wanted to know if she will still experience these side effects that she previously experienced during her first dose. She also mentioned that she had reported this to her physician and physician advised her to take Benadryl for the side effects(unknown if taken). Patient stated that she was not on any daily prescription medications, just two over the counter ones. No visit to emergency room or physician office. No any adverse event prior vaccination. No treatment was received for the events swelling of the face, face is red and blotchy, she is not sure if it is a rash, but the texture is not as smooth as usual, she would say it is rough and face is flushed. Outcome of the events swelling of the face, face is red and blotchy, she is not sure if it is a rash, but the texture is not as smooth as usual, she would say it is rough and face is flushed was not recovered and outcome of rest events was unknown at the time of reporting.  Follow-up attempts completed. No further information is expected.
Hospitalized 9.2.21 (still admitted); COVID-19 positive;  fully vaccinated  ASSESSMENT / PLAN:   COVID-19 positive Incidentally tested positive 9/2 (negative test on 8/6/21) Fully vaccinated with Pfizer in May 2021, per son  Asymptomatic, but unable to return to facility at this time Close monitoring of respiratory status    Failure to thrive Dementia Admitted 7/29-8/6 and ultimately placed at facility Son, has paperwork declaring him DPOA, he is requesting two physician evaluation to activate Care management consulted   DM II with long term insulin use Hgb A1c 10.5 in February, will recheck Hold home metformin Continue home dose Lantus 12 units nightly, add very low dose humalog   Essential hypertension Continue home lisinopril (5 mg daily)   CKD IIIa Per labs from last month: Cr 0.7 at baseline   Diet: general diet VTE ppx: lovenox subq (high risk in COVID) Code status: DNR, per discussion with guardian  Patient care was reviewed with Dr. whose input is reflected above. Disposition: placed in observation for monitoring since facility unwilling to accept pt with COVID-19. Hopeful discharge in 24-48 hours. HISTORY OF PRESENT ILLNESS: Pt. 88 y.o. female with history of insulin-dependent diabetes type 2, hypertension, hyperlipidemia, CKD 3, and dementia who resides at a  facillity.  Patient reportedly had an incidentally positive COVID test so was sent to the ER.  Patient is at her baseline mentation, oriented only to self.  She denies any complaints at this time.  Her son also states he had no report of new symptoms including cough, shortness of breath, fevers, chills, or weakness.  Patient was fully vaccinated with Pfizer vaccine in May. In the ER, patient was afebrile, normotensive, O2 sat 100% on room air, and heart rate in the 90s.  Per ER provider discussion with facility, they were unable to accept her back due to positive COVID status.  The patient was placed in observation with Internal Medicine for monitoring and placement.
Myalgia, Fever, Chills, Fatigue, Injection site pain, swelling at injection site Narrative:  Other Relevant History:
Swelling, redness, and tenderness of (R) upper arm from pneumonia shot 12 hrs later. Pt was advised to ice and MOTRIN.
Information has been received from a 56-year-old female with a medical history of seizure, a five year history of zoster and "postherpetic neuralgia (PHN)" (prior to vaccination), and an allergy to penicillin and erythromycin who in approximately November 2006 (November or December of 2006), was vaccinated with a dose of Zostavax (Oka/Merck).  The zoster and PHN prior to vaccination was in the facial and shoulder area on the left side.  Concomitant therapy included gabapentin (Neurontin) and primidone (Mysoline).  On an unspecified date the patient developed postherpetic neuralgia (PHN).  The PHN went away for 3 to 4 months after vaccination.  The patient reported a very occasional tingling during 3 to 4 month period following vaccination.  On an unspecified date the PHN has returned also on the left side of the face.  The patient is currently experiencing pain in the left ear.  At the time of the report the patient's status was not recovered.  A product quality complaint was not involved.  Additional information has been requested.
>36 days after getting first dose; Covid diagnosis after getting first dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (>36 days after getting first dose) and COVID-19 (Covid diagnosis after getting first dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (>36 days after getting first dose) and COVID-19 (Covid diagnosis after getting first dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (>36 days after getting first dose) had resolved and COVID-19 (Covid diagnosis after getting first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. Treatment medications were not reported.  Patient was scheduled to get the second dose on 24-Apr-2021 but did not. Patient was diagnosed with COVID 19 and has been under quarantine for a week and will continue until the 16-Sep-2021.
Developed itching, hives, dizziness, and flushing 30 minutes after receiving vaccine. Received Benadryl 25mg and solumedrol IM injection.
12/30/20  2:00 pm chills  5:00 pm fever 99.7, body aches, headache 12/31/20 AM swelling & redness at injection site , body aches, headache, chills, fatigue (slept a total of 17 hours)  12/31/20 headache, body aches 1/1/2021 feeling better, injection site stayed swollen and red until 1/4/2021
Pain at injection site that made it painful to move left arm. Headache.  Low grade fever of 99.2.
3/26/21 After Pfizer vaccine noticing hives on chest and left arm as well as facial tingling and slightly left eye itchiness.  Received 2 dose of Epinephrine during ED visit. 5/13/21 After Janssen vaccine he received at this morning around 8:10 AM.  After that he had almost the exact same symptoms with a shooting pain in the left arm and neck some left hand tingling and swelling to the point where he can't get his wedding ring off and a sensation of pressure/tingling/fullness in the left side.   Given Benadryl and steroids, initially there is no airway concerns or compromise.  However after a period of time, he thought his voice was different.  He did sound just slightly raspy, though I did question whether this could be related to dryness from the Benadryl.  Regardless given that he did note a change, we opted to go ahead and give a dose of epinephrine, which did resolve his symptoms
VACCINE WAS ADMINISTERED ON 10/1/2022,  1 DAY PAST ITS MFD EXPIRATION OF 9/30/2022
Follow up information received 08/13/02 from the physician provided lab results from 06/12/02. An allergist reported that a 40 year old female received a dose of Prevnar vaccine on 06/10/02, and that evening "Bactrim-DS generic" (sulfamethoxazole/trimethoprim) was initiated.The patient has a past medical history of panhypogammaglobulinemia and previously received three pneumococcal immunizations (manufacturer's unknown) (in 1981,1984 and 2002); she was tested for all 12 pneumococcal serotype and the results indicarted that the patient had non=protective antibodies. The patient developed a fever of 103 degrees F on the evening of vaccination. On 06/11/02, the patient developed a non-pruritic maculopapular skin rash over the dorsa of her feet, palmar and dorsal aspects of her hands and over her legs. Her ankles, knees, wrists and small joints of her hands and feet were swollen. The skin was described as "shiny and stretched." Lab values done on 06/12/02 included: Tryptase level was 11.8 ug/L (high); Complete blood count RBC was 3.80 mill/ul (low), Hct was 35.0 % (low), RDW was 11.9 (low), MPV was 7.5 fl (low); all other values including differential were within normal limits. Chemistry panel-Calcium was 8.8 mg/dL (low), TotPrt was 5.5 gm/lf (low), SGOT was 43 unit/L (high), SGPT was 77 unit/L (high), and all other values were within normal limits. Urinalysis values- Ph urine was 6.5 (high), Hgb urine was trace, leukocyte esterase was trace, bacteria urine was small, and other values were within normal limits. Complement total, C2 complement component and immune group values were within normal limits. The reporter indicated that the patient may have had an "adverse event to sulfa or Prevnar." The reporter also indicated that the symptoms may be suggestive of a "serum sickness type of reaction." Methylprednisolone (Medrol) dosepack was prescribed.
developed nausea and light headedness approximately 6 hours post vaccine.  patient unable to report to work the following day, symptoms then resolved.
After my booster I did feel the typical fatigue and body aches that would come and go. The fatigue was getting worse and in mid-January it got to a point where I then sought out medical care. It was found that I have high blood pressure, high cholesterol, an enlarged fatty liver, all found out through an ultrasound and blood tests. No prescription, however I was given instruction to lose weight and workout. I have begun working out more regularly and dieting. This led to a hospitalization due to almost passing out however I am still going to plan to workout and diet to get my health back to normal.
Found dead on May 3, 2021. Question day of death 05/01/2021.  Medical examiners case. Cause pending, possible SUDEP.
Erythema, warmth at the rash, pain, unable to use the arm since the day of injection. It is getting better slowly.